The online pharmacy is set to close a round co-led by Prosus Ventures at a $1.5bn post-money valuation, taking its overall funding past $670m.
Prosus Ventures, the investment arm of Prosus, the internet group formed by e-commerce and media company Naspers, is co-leading a $350m funding round for India-based online pharmacy PharmEasy, the Economic Times reported yesterday. The round consists of primary and secondary funding and is being co-led by TPG Growth, a vehicle for private equity group TPG.…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.